Cargando…

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis

MTBVAC is a live-attenuated Mycobacterium tuberculosis vaccine, currently under clinical development, that contains the major antigens ESAT6 and CFP10. These antigens are absent from the current tuberculosis vaccine, BCG. Here we compare the protection induced by BCG and MTBVAC in several mouse stra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguilo, Nacho, Gonzalo-Asensio, Jesus, Alvarez-Arguedas, Samuel, Marinova, Dessislava, Gomez, Ana Belen, Uranga, Santiago, Spallek, Ralf, Singh, Mahavir, Audran, Regine, Spertini, François, Martin, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519979/ https://www.ncbi.nlm.nih.gov/pubmed/28706226 http://dx.doi.org/10.1038/ncomms16085

Ejemplares similares

Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo
por: Uranga, Santiago, et al.
Publicado: (2016)

MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
por: Aguilo, Nacho, et al.
Publicado: (2016)

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
por: Gonzalo-Asensio, Jesus, et al.
Publicado: (2017)

Therapeutic efficacy of pulmonary live tuberculosis vaccines against established asthma by subverting local immune environment
por: Tarancón, Raquel, et al.
Publicado: (2021)

New insights into the transposition mechanisms of IS6110 and its dynamic distribution between Mycobacterium tuberculosis Complex lineages
por: Gonzalo-Asensio, Jesús, et al.
Publicado: (2018)

Bim is a crucial regulator of apoptosis induced by Mycobacterium tuberculosis
por: Aguiló, N, et al.
Publicado: (2014)

Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preference
por: Mata, Elena, et al.
Publicado: (2020)

Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potential
por: Pérez, Irene, et al.
Publicado: (2020)

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
por: Broset, Esther, et al.
Publicado: (2019)

The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy
por: Pérez, Irene, et al.
Publicado: (2022)

ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question
por: Aguiló, Nacho, et al.
Publicado: (2013)

Respiratory Immunization With a Whole Cell Inactivated Vaccine Induces Functional Mucosal Immunoglobulins Against Tuberculosis in Mice and Non-human Primates
por: Aguilo, Nacho, et al.
Publicado: (2020)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
por: Diogo, Gil R., et al.
Publicado: (2019)

Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B
por: Fuchs, Manon, et al.
Publicado: (2014)

Attenuated Mycobacterium tuberculosis SO2 Vaccine Candidate Is Unable to Induce Cell Death
por: Aporta, Adriana, et al.
Publicado: (2012)

Hypoxia Induces an Immunodominant Target of Tuberculosis Specific T Cells Absent from Common BCG Vaccines
por: Gideon, Hannah Priyadarshini, et al.
Publicado: (2010)

Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer
por: Sänger, Christian, et al.
Publicado: (2004)

Data-driven model for the assessment of Mycobacterium tuberculosis transmission in evolving demographic structures
por: Arregui, Sergio, et al.
Publicado: (2018)

Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis
por: Broset, Esther, et al.
Publicado: (2021)

Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis
por: Roy, Alvaro, et al.
Publicado: (2019)

Pathogenicity and virulence of Mycobacterium tuberculosis
por: Rahlwes, Kathryn C., et al.
Publicado: (2023)

A Subgroup of Latently Mycobacterium tuberculosis Infected Individuals Is Characterized by Consistently Elevated IgA Responses to Several Mycobacterial Antigens
por: Baumann, Ralf, et al.
Publicado: (2015)

Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis
por: DiChiara, Jeanne M., et al.
Publicado: (2010)

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)

Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
por: Reyes, Fátima, et al.
Publicado: (2013)

The M. tuberculosis Phosphate-Binding Lipoproteins PstS1 and PstS3 Induce Th1 and Th17 Responses That Are Not Associated with Protection against M. tuberculosis Infection
por: Palma, Carla, et al.
Publicado: (2011)

BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model
por: Singhal, Amit, et al.
Publicado: (2011)

The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
por: Henao-Tamayo, Marcela, et al.
Publicado: (2015)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
por: Vidal, Enric, et al.
Publicado: (2017)

Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
por: Bickett, Thomas E., et al.
Publicado: (2020)

Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection
por: Dijkman, Karin, et al.
Publicado: (2021)

BCG Vaccine: Tuberculosis—Cancer
por: Pimm, M. V.
Publicado: (1980)

BCG Vaccination and Tuberculosis in Japan
por: Rahman, Mahbubur, et al.
Publicado: (2007)

BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release
por: Owusu, Dorcas O., et al.
Publicado: (2023)

On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines
por: Arregui, Sergio, et al.
Publicado: (2016)

Role of phagocyte extracellular traps during Mycobacterium tuberculosis infections and tuberculosis disease processes
por: García-Bengoa, María, et al.
Publicado: (2023)

Recombinant HBHA Boosting Effect on BCG-Induced Immunity against Mycobacterium tuberculosis Infection
por: Guerrero, G. G., et al.
Publicado: (2011)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()
por: Poyntz, Hazel C., et al.
Publicado: (2014)

Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis
por: Tirado, Yanely, et al.
Publicado: (2015)

Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep
por: Balseiro, Ana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4m60ohp15kbqki3j3e0tmopg6m